These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Controversy grows over parallel track for experimental AIDS drug. N Y State J Med; 1990 Mar; 90(3):169. PubMed ID: 2107475 [No Abstract] [Full Text] [Related]
12. [AIDS studies with didanosine and stavudine]. Dtsch Med Wochenschr; 1996 May; 121(22):A30. PubMed ID: 8646981 [No Abstract] [Full Text] [Related]
13. Didanosine approved for advanced AIDS. Am Fam Physician; 1991 Dec; 44(6):2246. PubMed ID: 1746401 [No Abstract] [Full Text] [Related]
14. Second antiviral drug approved for AIDS. Del Med J; 1992 Mar; 64(3):219. PubMed ID: 1397404 [No Abstract] [Full Text] [Related]
15. Promising results for new AIDS/ARC drug. Nurs Stand; 1990 Jun 13-19; 4(38):16. PubMed ID: 2116821 [No Abstract] [Full Text] [Related]
16. Antiretroviral AIDS drug approved. AORN J; 1992 Feb; 55(2):605. PubMed ID: 1536553 [No Abstract] [Full Text] [Related]
17. T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. Naugler WE; Yong FH; Carey VJ; Dragavon JA; Coombs RW; Frenkel LM J Infect Dis; 2002 Feb; 185(4):448-55. PubMed ID: 11865396 [TBL] [Abstract][Full Text] [Related]
20. Hydroxyrea and ddI: French study published. James JS AIDS Treat News; 1995 Sep; (no 230):6. PubMed ID: 11362759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]